how do you feel after first dose of tirzepatide on Tirzepatide: What to Expect First dose of tirzepatide: what

Key Takeaways Tirzepatide (Zepbound) produces greater average weight loss than semaglutide (Wegovy) across both clinical trials and the first direct head-to-head comparison, 20.9% versus 14.9% in separate Phase 3 trials, and 20.2% versus 13.7% in the SURMOUNT-5 trial published in the New England Journal of Medicine

Some patients also experience diminished gastrointestinal side effects (such as nausea) after several months of treatment, which may have initially contributed to reduced food intake

Results vary based on the patient, formulation, treatment goals, health history and other factors

doi: 10.1080/15548627.2021.1872241 75 MunroHNLinderMC